Terumo Corp (4543):企業の財務・戦略的SWOT分析

【英語タイトル】Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C8360)・商品コード:DATA904C8360
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:59
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,625見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Terumo Corp (4543) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusion systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company’s systems find application in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through its subsidiaries and associate companies in Japan, China, Europe, North America, South America, and Asia (excluding China and Japan). Terumo is headquartered in Tokyo, Japan.

Terumo Corp Key Recent Developments

Oct 09,2018: UniCAR Therapy and Terumo BCT Collaborate to Advance CAR T-Cell Therapies and Create a Shanghai, China Center of Excellence
Oct 03,2018: Cognate BioServices and Terumo BCT Announce Letter of Intent for Collaboration Agreement for Innovation and Development Center of Excellence in Memphis, TN.
Oct 03,2018: Cognate BioServices and Terumo BCT Announce Letter of Intent for Collaboration Agreement for Innovation and Development Center of Excellence in Memphis TN
Sep 18,2018: Cellular therapy CDMO Cognate to create center of excellence with Terumo
Aug 16,2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Terumo Corp – Key Facts 6
Terumo Corp – Key Employees 7
Terumo Corp – Key Employee Biographies 10
Terumo Corp – Key Operational Employees 11
Terumo Corp – Major Products and Services 12
Terumo Corp – History 14
Terumo Corp – Company Statement 20
Terumo Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 24
Section 2 – Company Analysis 25
Company Overview 25
Terumo Corp – Business Description 26
Business Segment: Blood Management Company 26
Overview 26
Performance 26
Business Segment: Cardiac and Vascular Company 26
Overview 26
Performance 27
Business Segment: General Hospital Company 27
Overview 27
Performance 27
Geographical Segment: Americas 28
Performance 28
Geographical Segment: Asia and Others 28
Performance 28
Geographical Segment: Europe 28
Performance 28
Geographical Segment: Japan 28
Performance 28
R&D Overview 28
Terumo Corp – Corporate Strategy 29
Terumo Corp – SWOT Analysis 30
SWOT Analysis – Overview 30
Terumo Corp – Strengths 30
Terumo Corp – Weaknesses 31
Terumo Corp – Opportunities 32
Terumo Corp – Threats 33
Terumo Corp – Key Competitors 34
Section 3 – Company Financial Ratios 35
Financial Ratios – Capital Market Ratios 35
Financial Ratios – Annual Ratios 36
Performance Chart 39
Financial Performance 39
Financial Ratios – Interim Ratios 40
Financial Ratios – Ratio Charts 41
Section 4 – Company’s Lifesciences Financial Deals and Alliances 42
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Terumo Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 43
Terumo Corp, Recent Deals Summary 44
Section 5 – Company’s Recent Developments 45
Aug 16, 2018: President and CEO of Terumo BCT David Perez to Retire after FY 2018 Antoinette Gawin Named as Successor 45
Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor 46
Aug 06, 2018: Terumo’s affiliate in china to receive an approval for PD solution 47
Jul 09, 2018: Terumo to Increase Production Capacity for Alliance Business Pre-filled Syringes Capital Investment of 7 Billion Yen in Terumo Yamaguchi D&D Corporation 48
Jul 04, 2018: Terumo Announces Shipping Delays for Products from Ashitaka Factory 49
May 11, 2018: Terumo Appoints its U.S. based Subsidiary’s Associate as the Fifth Terumo Fellow 50
Apr 23, 2018: Vascutek and Bolton Medical Merge as ‘Terumo Aortic’ 51
Feb 26, 2018: Terumo Pharmaceutical Solutions wins Asia-Pacific Industry Award 52
Feb 13, 2018: Terumo Announces £33m Investment in Scottish Medical Device Factory 53
Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 54
Section 6 – Appendix 55
Methodology 55
Ratio Definitions 55
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Terumo Corp, Key Facts 6
Terumo Corp, Key Employees 7
Terumo Corp, Key Employee Biographies 10
Terumo Corp, Key Operational Employees 11
Terumo Corp, Major Products and Services 12
Terumo Corp, History 14
Terumo Corp, Other Locations 21
Terumo Corp, Subsidiaries 22
Terumo Corp, Joint Venture 24
Terumo Corp, Key Competitors 34
Terumo Corp, Ratios based on current share price 35
Terumo Corp, Annual Ratios 36
Terumo Corp, Annual Ratios (Cont...1) 37
Terumo Corp, Annual Ratios (Cont...2) 38
Terumo Corp, Interim Ratios 40
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Terumo Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018 43
Terumo Corp, Recent Deals Summary 44
Currency Codes 55
Capital Market Ratios 55
Equity Ratios 56
Profitability Ratios 56
Cost Ratios 57
Liquidity Ratios 57
Leverage Ratios 58
Efficiency Ratios 58

List of Figures
Terumo Corp, Performance Chart (2014 - 2018) 39
Terumo Corp, Ratio Charts 41
Terumo Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 42
Terumo Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 43

★調査レポート[Terumo Corp (4543):企業の財務・戦略的SWOT分析] (コード:DATA904C8360)販売に関する免責事項を必ずご確認ください。
★調査レポート[Terumo Corp (4543):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆